PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Manulife Financial Corp (MFC-PM.TO)
23.680.18 (-0.75%)
23.68 - 23.68
20.75 - 25.07
1.4K / 5.9K (Avg.)
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
10.31%
Revenue growth exceeding 1.5x Insurance - Life median of 0.27%. Joel Greenblatt would verify if operating margins keep pace with this top-line surge.
10.31%
Gross profit growth exceeding 1.5x Insurance - Life median of 0.27%. Joel Greenblatt would check if cost advantages or brand equity drive this surge.
63.01%
EBIT growth of 63.01% while Insurance - Life median is zero. Walter Schloss would see a marginal edge that could be expanded upon.
63.01%
Operating income growth of 63.01% while Insurance - Life median is zero. Walter Schloss might see a modest advantage that can expand.
60.18%
Positive net income growth while Insurance - Life median is negative. Peter Lynch would view this as a notable competitive advantage.
60.17%
EPS growth of 60.17% while Insurance - Life median is zero. Walter Schloss might see a slight edge that could compound over time.
60.17%
Diluted EPS growth of 60.17% while Insurance - Life median is zero. Walter Schloss might see a slight edge that could improve over time.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
12.70%
OCF growth exceeding 1.5x Insurance - Life median of 7.05%. Joel Greenblatt would see if a superior business model or cost structure drives strong cash generation.
12.70%
FCF growth exceeding 1.5x Insurance - Life median of 7.05%. Joel Greenblatt would see if high profitability or prudent capex drives outperformance.
281.63%
10Y revenue/share CAGR exceeding 1.5x Insurance - Life median of 69.69%. Joel Greenblatt would verify if a unique moat or brand fosters outperformance over a decade.
56.81%
5Y revenue/share growth exceeding 1.5x Insurance - Life median of 7.98%. Joel Greenblatt would see if the company’s moat drives rapid mid-term expansion.
40.40%
3Y revenue/share growth exceeding 1.5x Insurance - Life median of 4.01%. Joel Greenblatt might see a short-term competitive advantage at play.
758.85%
OCF/share CAGR exceeding 1.5x Insurance - Life median of 117.12% over 10 years. Joel Greenblatt would verify if a unique competitive moat underlies these cash flows.
105.41%
5Y OCF/share growth exceeding 1.5x Insurance - Life median of 58.08%. Joel Greenblatt might see a strong moat or efficient cost structure driving outperformance.
63.10%
3Y OCF/share growth > 1.5x Insurance - Life median of 39.68%. Joel Greenblatt might see a recent competitive advantage translating into cash improvements.
-399.71%
Negative 10Y net income/share CAGR vs. Insurance - Life median of 20.37%. Seth Klarman might see a fundamental problem if peers maintain growth.
-227.10%
Negative 5Y CAGR while Insurance - Life median is -2.75%. Seth Klarman might see a specific weakness if peers maintain profitable expansions.
-188.49%
Negative 3Y CAGR while Insurance - Life median is -13.54%. Seth Klarman might see a pressing concern if the rest of the sector is stable or growing.
234.09%
Equity/share CAGR exceeding 1.5x Insurance - Life median of 44.51% over 10 years. Joel Greenblatt would see if a high ROE underlies this compounding advantage.
11.02%
5Y equity/share CAGR 75-90% of Insurance - Life median. John Neff calls for higher returns or more efficient buybacks to match peers.
7.78%
3Y equity/share CAGR of 7.78% while Insurance - Life median is zero. Walter Schloss sees a modest short-term advantage that could compound if momentum persists.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
3.59%
Asset growth near Insurance - Life median. Charlie Munger attributes it to a typical industry cycle of capital investment.
-6.27%
Negative BV/share change while Insurance - Life median is 0.86%. Seth Klarman sees a firm-specific weakness if peers accumulate net worth.
42.90%
Debt growth far outpacing Insurance - Life median. Jim Chanos suspects over-leveraging or deteriorating financial discipline.
No Data
No Data available this quarter, please select a different quarter.
-0.06%
SG&A decline while Insurance - Life grows. Seth Klarman sees potential cost advantage or a risk if it hurts future growth.